Skip to content

Outpatient Y-90 Solutions Program

Outpatient Y-90 Solutions from Sirtex

Y-90 Service Offerings Designed to Meet the Unique Needs of the Outpatient Setting

 

The Sirtex Outpatient Solutions Program is where outpatient expertise meets Y-90 innovation. We offer tailored solutions and experienced support in launching Y-90 programs in the outpatient setting. With Sirtex’s specialized support, clinicians can focus on the day-to-day administration of their practice, while working to increase Y-90 availability and quality of care for appropriate patients.

  • Product Support: SIR-Spheres® Y-90 resin microspheres offer the flexibility to order, map, then treat your patients with 3 delivery options, 5 days a week so that you can focus on expedited patient treatment, not the schedule.
  • Clinical Support: The Medical Science Liaison team is readily available to engage in scientific discussions and provide best practices that may guide you in making clinical decisions.
  • Licensing Support: Our knowledgeable Radiation Safety team can help your office navigate complex local and national regulations.
  • Reimbursement Support: Sirtex’s dedicated Healthcare Economics team will help inform your decision-making process prior to launching a Y-90 program in your office.
  • Launch Support: Experienced National Outpatient Solutions staff, dedicated to evaluate launch readiness and Y-90 workflow.
  • Centers of Education (COE): An in-person experience at one of our COE locations throughout the country where interested physicians, mid-levels and applicable staff can get the hands-on education they need to be able to offer Y-90 in the outpatient setting.
thumbnail
download
Outpatient Y-90 Solutions Program Sell Sheet
thumbnail
download
Improved Y-90 Patient Experience in a Multispecialty Oncology Practice
thumbnail
Determining Y-90 dosing without dosimetry software

Dr. Alexa Levey, Interventional Radiologist from Memorial Hermann Health System, Houston Texas, shares how she determines the appropriate Y-90 dosing without dosimetry software.

thumbnail
Setting up a Y-90 service in an Interventional Radiology Private Practice

Dr. Alexa Levey, Interventional Radiologist from Memorial Hermann Health System, Houston Texas, speaks with Sirtex about how to build a successful Y-90 practice.

To learn more, please complete the form below.


* We are collecting this personal information in order to respond to the inquiry you are sending via this form. SIRTEX understands the importance of protecting your information and will use your information for the sole purpose of responding to your inquiry.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician Indications for Use: SIR-Spheres® Y-90 resin microspheres are indicated for the local tumor control of unresectable hepatocellular carcinoma (HCC) in patients with no macrovascular invasion, Child Pugh-A cirrhosis, well-compensated liver function, and good performance status. They are also indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Side Effects: Common side effects are fever, transient decrease of hemoglobin, mild to moderate abnormality of liver function tests, abdominal pain, nausea, vomiting, and diarrhea. Potential serious effects due to exposure to high radiation include acute pancreatitis, radiation pneumonitis, acute gastritis, acute cholecystitis and radioembolization induced liver disease (REILD). Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.